We describe a novel isothermal gas-chromatographic procedure for measuring valproic acid. Plasma, with cyclohexanecarboxylicacid added as internal standard,is selectively extracted with pentane to minimize the extraction of other acidic drugs. To convert carboxylic acids to their phenacyl esters, ct-bromoacetophenone is added to the organic extract before evaporating the solvent. These esters are relatively less volatile than the acids themselves and the extractingsolventcan be removed without any loss of valproic acid or internal standard. The phenacyl esters, when chromatographed on 3% OV-17, produce sharp, well-shaped peaks and show high response for the flame ionization detector. Valproic acid is well separated from the internal standard, from reagents and plasma constituents, and from some commonly prescribed drugs that we examined. When t-bromo-p-nitroacetophenone isused as the derivatizing agent,the resulting nitrophenacyl esters can be analyzed with use of a nitrogen-specific detector.
Many gas-chromatographic procedures have been described fr assay of VA in body fluids (1-15). In most of these procedures, columns packed with liquid phases are used which are suitable for the analysis of free VA. The twin problem of losses of VA during concentration of plasma extracts and of adsorption of VA on gas-chromatographic columns and/or supports was realized by early workers (I) . In some recently published procedures (6-9, 12, 15) , the problem of losses of VA has been avoided by using a small volume of extracting solvent and analyzing the extract by gas chromatography without first concentrating it. However, on occasion it is extremely difficult to obtain extracts that are completely free from aqueous phase or protein layer when the solvent/specimen ratio by volume is less than 1. Further, well-shaped peaks are obtained initially when free fatty acids are analyzed with use of various liquid phases; tailing of peaks and ghosting occur when the columns have been in use for some time (16 Blood from patients receiving valproate therapy was drawn in the morning, be6re the first morning dose, into heparinized evacuated blood-collection tubes. Plasma was separated within 2 h of blood collection and stored at 4 #{176}C. The specimens were frozen when they were to be stored fr more than five days.
Materials and Methods
To 0.25 mL of' plasma (standard or test) in Teflon-lined screw-capped culture tubes (16 X 1(X) mm), we added 0.25 mL The tubes were kept well-stoppered until their contents were analyzed by gas chromatography.
We used a gas chromatograph (Model 2700; Varian, Georgetown, Ontario) equipped with a flame ionization detector. A 2-m glass column (2 mm i.d.) was packed with 3% OV-17 on Gas Chrom Q,80-100 mesh (Applied Science Laboratories, State College, PA 16801). This column was conditioned overnight at 250#{176}C with a carrier gas flow of about 30 mL/min.
The analysis was carried out isothermally with the oven temperature at 205 #{176}C and the injector and detector at A-25 ) and the areas of the peaks were computed with an Autolab System IV integrator (Spectraphysics Inc., Santa Clara, CA 95051).
Results and Discussion
After the internal standard is added, we wash plasma at a pH of about 10 with pentane to remove some of the neutral and basic impurities.
Carboxylic acids and other acidic drugs are not extracted at this pH. Omission of this step does not produce extra peaks during gas-chromatographic analysis. However, it has been included to ensure clean plasma extracts for a relatively long column life. After adjusting the pH of plasma to <2, we extract it with pentane, in a high solvent/ specimen ratio that allows easy collection of the organic (upper) layer. The uncorrected analytical recovery of VA is about 70% as determined by analyzing supplemented plasma without the addition of internal standard and comparing the peak heights of the same aliquots of non-extracted standards (after derivatization).
Addition of internal standard obviates the need foraccurate measurement of solventsor extracts.
There does not appear to be any loss of VA or of internal standard when the plasma extract is evaporated after the addition of derivatizing agent (-bromoacetophenone + tnethylamine).
There was no increase in the yield of phenacyl metrical peaks on gas-chromatographic analysis with a liquid phase of 3% OV-17.
We conclude that this procedure is an acceptable routine method for measuring VA with use of a column that is commonly used for the gas-chromatographic analysis of other anti-epileptic drugs. Methyl esters of VA have been chromatographed with the use of similar silicone phases (8, 11) , but these procedures do not adequately overcome the problem of volatility of VA.
esters of VA when denivatization was carried out overnight at room temperature or at 37 #{176}C, followed by evaporation of solvent at 50-55 #{176}C. The yield from the denivatization was also unaffected by increasing the amount of denivatizing agent. The high sensitivity of the procedure indicates nearly complete conversion of VA and the internal standard to their phenacyl esters. Preparation of phenacyl esters have been described for the liquid-chromatographic analysis of fatty acids (17, 18) because these esters show high absorbance at 254 nm. Preparation of p-bromo-and p-phenylphenacyl esters has also been suggested for gas chromatography analysis of fatty acids (20) . We have chosen to use triethylamine and not the crown ethers (17) for the formation of phenacyl esters, because the crown ethers leave residue on the column if the denivatization is done by the simple one-step procedure we described.
We selected 3% OV-17 as the liquid phase for the analysis of phenacyl esters because it is commonly used in the assay of anti-epileptic and other drugs. No special treatment of the column is required before or after the analysis of phenacyl esters. In a recent report, columns packed with 5% OV-17 had to be primed with hydrochloric acid before gas chromatography analysis of methyl ester of VA (8) . Peaks of extractable impurities from plasma and of reagents are eluted early, while the sharp and symmetrical peaks of derivatives of VA and the internal standard appear late and are well separated ( Figure  1 ). There is no evidence that phenacyl esters form multiple peaks. These esters are stable at room temperature for at least 48 h when stored in stoppered tubes, either as dry residue or dissolved in methanol.
We found the standard curve to be linear for the range tested (10-200mg of VA per liter of plasma), eitherby comparing the ratio of peak areas obtained by electronic integration or by comparing ratios of peak heights for VA and internal standard. The calibration curves pass through the origin (Figure 2 ). The lower limit for quantitation of VA is 2 mg/L for a 250-ML specimen. This procedure is satisfactorily reproducible (Table 1) .
Acidic drugs or indigenous metabolites extractable at acidic pH might be present in the plasma extract. However, nonpolar solvents such as pentane or hexane do not efficiently extract several of the anti-epileptic drugs (19) . We have not observed any interference when plasma supplemented with any of several compounds was analyzed by the present procedure (Table 2, Figure 1) . We have analyzed some specimens from patients receiving therapy with valproic acid. Most of them (68%) showed concentrations in plasma that were within the therapeutic range, 50-100 mg/L (Table 3) .
In some laboratories, anti-epileptic drugs in plasma are measured by gas chromatography with use of a nitrogenspecific detector. A flame ionization detector has to be used for VA because it contains no nitrogen. We have prepared nitrophenacyl esters of VA and internal standard by replacing a-bromoacetophenone with a-bromo-p -nitro-acetophenone (K and K Labs., Plainview, NY 11803). These nitrophenacyl esters show good response with both a flame ionization and a nitrogen-specific detector, and produce sharp and sym-
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